abstract |
The invention relates to intravascular stents comprising in its inner surface an enzyme capable of catabolizing cholesterol and lipids, such as lipase, or cells that have been genetically modified to produce said enzyme, and to their use in the frame of the treatment or prevention of obstructive artheriosclerotic lesions in the coronary and peripheral blood vessels, or prevention of restenosis in intra coronaric stents. |